Results 161 to 170 of about 3,258,233 (341)

Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial [PDF]

, 2002
David J.A. Jenkins, Cyril W.C. Kendall, Vladimir Vuksan, Edward Vidgen, Tina Parker, Dorothea Faulkner, Christine C. Mehling, Marcella Garsetti, G. Testolin, Stephen C. Cunnane, Mary Ann Ryan, Paul Corey   +11 more
openalex   +1 more source

Probing Early Particle‐Cell Membrane Interactions via Single‐Cell and Single‐Particle Interaction Analysis

Advanced Functional Materials, EarlyView.
The pre‐internalization phase of endocytosis remains poorly characterized at single‐cell levels. Single‐cell pre‐internalization mechanics are investigated using advanced robotic techniques. Cancer cells exhibit biphasic adhesion – rapid initial binding followed by reinforcement – while fibroblasts show gradual engagement.
Houari Bettahar, Christos Tapeinos, Oğulcan Işıtman, Carmine D'Amico, Alexandra Correia, Hélder A. Santos, Quan Zhou   +6 more
wiley   +1 more source

A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2024. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Aksoyalp ZS, Kayki-Mutlu G, Wojnowski L, Michel MC.   +3 more
europepmc   +1 more source

A Short Course on the Food and Drug Administration: What You Should Know [PDF]

, 2002
Jean L. Fourcroy
openalex   +1 more source

Urokinase and the US Food and Drug Administration [PDF]

Journal of Vascular Surgery, 1999
openaire   +3 more sources

Microbubble‐Controlled Delivery of Biofilm‐Targeting Nanoparticles to Treat MRSA Infection

Advanced Functional Materials, EarlyView.
Here, an effective strategy using microbubble (MB)‐controlled delivery of biofilm‐targeting nanoparticles (BTNs) for removal and therapy of methicillin‐resistant Staphylococcus aureus (MRSA) biofilm infections is introduced. In vivo delivery of MB with BTN is demonstrated to silence key bacterial genes involved in biofilm formation (icaA), bacterial ...
Ju Yeon Chung, Yujin Ahn, Joo Hun Lee, Seungju Yang, Seung Cheol Lee, Hyunjoon Kong, Hyun Jung Chung   +6 more
wiley   +1 more source

Evidence available and used by the Food and Drug Administration for the approval of orphan and nonorphan drugs. [PDF]

Health Aff Sch
Koong AJ, Irvin VL, Narayan A, Song S, Kaplan RM.   +4 more
europepmc   +1 more source

Recalls of Foods and Cosmetics Due to Microbial Contamination Reported to the U.S. Food and Drug Administration

, 2000
Stephanie Wong, Debra Street, Sonia I. Delgado, Karl C. Klontz   +3 more
openalex   +1 more source

US Food and Drug Administration gets it right [PDF]

, 2002
Matthew Grove
openalex   +1 more source

Bioengineering Strategies for Treating Neointimal Hyperplasia in Peripheral Vasculature: Innovations and Challenges

Advanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
This review highlights emerging bioengineering strategies for treating neointimal hyperplasia in the peripheral vasculature, focusing on approaches that promote re‐endothelialization, modulate smooth muscle cell phenotype, reduce inflammation, mitigate oxidative stress, and optimize biomechanical compliance.
Nikita Wilson John, Caitlyn Dang, Nidhi Reddy, Calvin Chao, Karen J. Ho, Bin Jiang   +5 more
wiley   +1 more source